| PERIOD ENDING | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | 30-Jun-07 | | Total Revenue | 3,763,000 | 3,197,000 | 2,763,000 | 2,929,000 | | Cost of Revenue | 1,022,000 | 587,000 | 542,000 | 339,000 | | | Gross Profit | 2,741,000 | 2,610,000 | 2,221,000 | 2,590,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 148,000 | 470,000 | 427,000 | 644,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 816,000 | 794,000 | 811,000 | 676,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,777,000 | 1,346,000 | 983,000 | 1,270,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (783,000) | 30,000 | 86,000 | (9,000) | | Earnings Before Interest And Taxes | 994,000 | 1,376,000 | 1,069,000 | 1,261,000 | | Interest Expense | 102,000 | 105,000 | 108,000 | 107,000 | | Income Before Tax | 892,000 | 1,271,000 | 961,000 | 1,154,000 | | Income Tax Expense | 241,000 | 167,000 | 317,000 | 330,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 651,000 | 1,104,000 | 644,000 | 824,000 | | | Non-recurring Events | | Discontinued Operations | 98,000 | 212,000 | 91,000 | 80,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 749,000 | 1,316,000 | 735,000 | 904,000 | | Preferred Stock And Other Adjustments | (2,000) | (3,000) | (2,000) | (3,000) | | | Net Income Applicable To Common Shares | $747,000 | $1,313,000 | $733,000 | $901,000 |
|
0.19% Nasdaq 
Income Statement
